School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Fuad El Rassi

  • Department of Hematology and Medical Oncology
    Associate Professor
  • (404) 778-1480
  • fuad.elrassi@emory.edu
Head shot of Fuad El Rassi

Overview

A board certified hematologist, Dr. El Rassi treats patients with sickle cell anemia and other blood disorders. He leads the sickle cell research program at Grady Health System, where investigational agents and curative treatments are being considered in phase I, II and III clinical trials. Additionally, Dr. El Rassi treats patients in benign hematology at Emory University Hospital Midtown.

Dr. El Rassi is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institue. He is a board member and serves as treasurer for the Sickle Cell Adult Provider Network. He is also involved in hematology and medical oncology fellows' training and education in benign hematology and chairs the Fellowship Competency Committee.

Dr. El Rassi received his Medical Degree from the American University of Beirut in Beirut, Lebanon. His postgraduate medical training included a residency in internal medicine at Saint Louis University Hospital and a fellowship in the Department of Hematology and Medical Oncology at the Winship Cancer Institute of Emory University.

Dr. El Rassi's research work is focused on the development of novel approaches to improve the treatment of acute myeloid leukemia, management of sickle cell disease, and iron overload.

Academic Appointment

  • Associate Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine

Education

Degrees

  • MD from American University of Beirut, Beirut

Research

Publications

  • The Mortality of Adults With Sickle Cell Disease at a Comprehensive Sickle Cell Center.
    Eur J Haematol Volume: 114 Page(s): 663 - 671
    04/01/2025 Authors: Afranie-Sakyi JA; Randall E; Fasano R; McLemore ML; El Rassi F
  • Hematopoietic cell transplant compared with standard care in adolescents and young adults with sickle cell disease.
    Blood Adv Volume: 9 Page(s): 955 - 965
    03/11/2025 Authors: Walters MC; Eapen M; Liu Y; El Rassi F; Waller EK; Levine JE; Strouse JJ; Antin JH; Parikh SH; Bakshi N
  • Long-term quality of life after hematopoietic cell transplant for sickle cell disease in childhood: A STELLAR interim analysis.
    Am J Hematol Volume: 99 Page(s): 2037 - 2040
    10/01/2024 Authors: Arnold SD; Bakshi N; Ross D; Smith C; Sinha C; Veludhandi A; Dutreuil V; Bai S; Meacham LR; Guilcher G
  • Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1-2 trial.
    Lancet Haematol Volume: 11 Page(s): e345 - e357
    05/01/2024 Authors: Gladwin MT; Gordeuk VR; Desai PC; Minniti C; Novelli EM; Morris CR; Ataga KI; De Castro L; Curtis SA; El Rassi F
  • Enhanced IgG immune response to COVID-19 vaccination in patients with sickle cell disease.
    Br J Haematol Volume: 202 Page(s): 937 - 941
    09/01/2023 Authors: Nakahara H; Cheedarla N; Verkerke HP; Cheedarla S; Wu S-C; Hendrickson JE; Chang A; McLemore ML; El Rassi F; Roback JD
  • Presentations and outcomes among sickle cell disease patients with COVID-19 at a large southern healthcare system.
    Expert Rev Hematol Volume: 16 Page(s): 151 - 156
    02/01/2023 Authors: Clarke K; Shin YM; Hall MAK; Moussa M; McLemore M; El Rassi F
  • A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis.
    Blood Volume: 141 Page(s): 168 - 179
    01/12/2023 Authors: Dampier CD; Telen MJ; Wun T; Brown RC; Desai P; El Rassi F; Fuh B; Kanter J; Pastore Y; Rothman J
  • Burden of disease, treatment utilization, and the impact on education and employment in patients with sickle cell disease: A comparative analysis of high- and low- to middle-income countries for the international Sickle Cell World Assessment Survey.
    Am J Hematol Volume: 97 Page(s): 1055 - 1064
    08/01/2022 Authors: Osunkwo I; James J; El-Rassi F; Nero A; Minniti CP; Trimnell C; Paulose J; Ramscar N; Bailey T; Rajkovic-Hooley O
  • Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study.
    JMIR Res Protoc Volume: 11 Page(s): e36780
    07/06/2022 Authors: Krishnamurti L; Arnold SD; Haight A; Abraham A; Guilcher GM; John T; Bakshi N; Shenoy S; Syrjala K; Martin PL
  • Sickle Cell Disease and Kidney.
    Adv Chronic Kidney Dis Volume: 29 Page(s): 141 - 148.e1
    03/01/2022 Authors: Amarapurkar P; Roberts L; Navarrete J; El Rassi F
  • Catastrophic Neurological Complications in 2 Patients With Sickle Cell Disease and COVID-19.
    J Investig Med High Impact Case Rep Volume: 10 Page(s): 23247096221111778
    01/01/2022 Authors: Clarke K; Benameur K; Wiley Z; Shin YM; Moussa M; El Rassi F; McLemore M
  • High Rates of Transfusion in Pregnant Women with Sickle Cell Disease (SCD): A Retrospective Chart Review
    Volume: 61 Page(s): 187A - 188A
    09/01/2021 Authors: Rollins MR; El Rassi F; Lancelot M; Ha TK; Leong T; Xiang Y; Kottke M; Chou ST
  • Impact of sickle cell disease on patients' daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY).
    Am J Hematol Volume: 96 Page(s): 404 - 417
    04/01/2021 Authors: Osunkwo I; Andemariam B; Minniti CP; Inusa BPD; El Rassi F; Francis-Gibson B; Nero A; Trimnell C; Abboud MR; Arlet J-B
  • Outcomes of Chronic Phase Chronic Myeloid Leukemia after Treatment with Multiple Tyrosine Kinase Inhibitors.
    J Clin Med Volume: 9
    05/20/2020 Authors: Kong JH; Winton EF; Heffner LT; Gaddh M; Hill B; Neely J; Hatcher A; Joseph M; Arellano M; El-Rassi F
  • IMPACT OF SICKLE CELL DISEASE SYMPTOMS ON PATIENTS' DAILY LIVES IN THE US - PATIENTS FROM THE SICKLE CELL WORLD ASSESSMENT SURVEY (SWAY)
    Volume: 23 Page(s): S343 - S343
    05/01/2020 Authors: Osunkwo I; Andemariam B; Inusa B; El Rassi F; Nero A; Minniti C; Arlet JB; Colombatti R; Jain S; Jastaniah W
  • A Phase II Trial to Compare Allogeneic Transplant Vs. Standard of Care for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 1503
    Volume: 134
    11/13/2019 Authors: Eapen M; Neuberg DS; Mendizabal AM; Stevenson KE; Antin JH; DiFronzo N; El Rassi FA; Lulla P; Waller EK; Garrison J
  • Management Strategies and Satisfaction Levels in Patients with Sickle Cell Disease: Interim Results from the International Sickle Cell World Assessment Survey (SWAY)
    Volume: 134
    11/13/2019 Authors: James J; Andemariam B; Inusa BPD; El-Rassi F; Francis-Gibson B; Nero AC; Minniti CP; Trimnell C; Abboud MR; Arlet J-B
  • Impact of Sickle Cell Disease Symptoms on Patients' Daily Lives: Interim Results from the International Sickle Cell World Assessment Survey (SWAY)
    Volume: 134
    11/13/2019 Authors: Osunkwo II; Andemariam B; Inusa BPD; El-Rassi F; Francis-Gibson B; Nero AC; Minniti CP; Trimnell C; Abboud MR; Arlet J-B
  • Evaluating Thrombocytopenia and Other Biomarkers in Multi-Organ Failure during Sickle Cell Crisis
    Volume: 134
    11/13/2019 Authors: Shanmugasundaram K; Higgins I; El Rassi FA; McLemore ML
  • Characteristics of Sickle Cell Clinic Visits and Hospital Admissions in a Large Urban Academic Hospital
    Volume: 134
    11/13/2019 Authors: Odikadze L; McLemore ML; Stoyanova N; El Rassi FA
  • Examining Female Patients With Sickle Cell Disease Attitudes and Beliefs About Contraceptives
    Volume: 133 Page(s): 86S - 87S
    05/01/2019 Authors: Piper K; El Rassi F; McLemore M; Kottke MJ
  • Challenges in the treatment and prevention of delayed hemolytic transfusion reactions with hyperhemolysis in sickle cell disease patients.
    Transfusion Volume: 59 Page(s): 1698 - 1705
    05/01/2019 Authors: Dean CL; Maier CL; Chonat S; Chang A; Carden MA; El Rassi F; McLemore ML; Stowell SR; Fasano RM
  • Extreme hyperbilirubinemia: An indicator of morbidity and mortality in sickle cell disease.
    World J Hepatol Volume: 11 Page(s): 287 - 293
    03/27/2019 Authors: Haydek JP; Taborda C; Shah R; Reshamwala PA; McLemore ML; Rassi FE; Chawla S
  • Iron overload in patients with myelodysplastic syndromes: An updated overview.
    Cancer Volume: 124 Page(s): 3979 - 3989
    10/15/2018 Authors: Moukalled NM; El Rassi FA; Temraz SN; Taher AT
  • Transfusion-transmitted malaria masquerading as sickle cell crisis with multisystem organ failure.
    Transfusion Volume: 58 Page(s): 1550 - 1554
    06/01/2018 Authors: Maier CL; Gross PJ; Dean CL; Chonat S; Ip A; McLemore M; El Rassi F; Stowell SR; Josephson CD; Fasano RM
  • EXTREME HYPERBILIRUBINEMIA: AN INDICATOR OF INCREASED MORBIDITY AND MORTALITY IN PATIENTS WITH SICKLE CELL DISEASE
    Volume: 154 Page(s): S1211 - S1211
    05/01/2018 Authors: Haydek JP; Vidarte CT; Shah R; Reshamwala PA; El Rassi F; McLemore ML; Chawla S
  • Exploring Attitudes, Beliefs and Behavior Towards Hormonal Birth Control Among Female Patients with Sickle Cell Disease through Semi-Structured Interviews
    Volume: 130
    12/07/2017 Authors: Kendra P; El Rassi F; McLemore ML; Kottke M
  • Pulmonary Embolism in Sickle Cell Disease: Retrospective Analysis of the Use and Yield of Radiographic Studies
    Volume: 130
    12/07/2017 Authors: Gopalsamy SN; El Rassi F; McLemore ML
  • Outcomes of Chronic Phase Chronic Myeloid Leukemia (CP-CML) after Sequential Treatment with Tyrosine Kinase Inhibitors (TKI)
    Volume: 130
    12/07/2017 Authors: Kong JH; Winton EF; Heffner L; Gaddh M; Hill B; Arellano ML; El-Rassi F; Kim A; Kota V
  • Outcomes after Sequential Tyrosine Kinase Inhibitors Treatment in Chronic Phase Chronic Myeloid Leukemia
    Volume: 130
    12/07/2017 Authors: Kong JH; Winton EF; Heffner L; Gaddh M; Hill B; Arellano M; El-Rassi F; Kim A; Jillella A; Kota VK
  • Outcomes of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Following an Elective Switch From Second-Generation Tyrosine Kinase Inhibitor to Imatinib.
    Clin Lymphoma Myeloma Leuk Volume: 17 Page(s): e71 - e73
    12/01/2017 Authors: Kota VK; Kong JH; Arellano M; El Rassi F; Gaddh M; Heffner LT; Winton EF; Jillella AP; McLemore ML; Khoury HJ
  • Qualitative exploration of the sexual and reproductive health of a patient population with sickle cell anemia
    Volume: 96 Page(s): 305 - 305
    10/01/2017 Authors: Piper K; El Rassi F; McLemore M; Kottke M
  • Alloantibody Responder Status Fails to Predict Immune Response to Pneumovax
    Volume: 57 Page(s): 168A - 168A
    09/01/2017 Authors: Shah K; Sullivan C; Stowell J; Dean CL; Jessup P; McLemore M; El Rassi F; Stowell S; Fasano R
  • Does the frequency of molecular monitoring after tyrosine kinase inhibitor discontinuation affect outcomes of patients with chronic myeloid leukemia?
    Cancer Volume: 123 Page(s): 2482 - 2488
    07/01/2017 Authors: Kong JH; Winton EF; Heffner LT; Chen Z; Langston AA; Hill B; Arellano M; El-Rassi F; Kim A; Jillella A
  • TUBE TROUBLES: AN UNCOMMON CAUSE OF NEUTROPENIA
    Volume: 32 Page(s): S626 - S626
    04/01/2017 Authors: Haydek JP; Xu KM; Poppens ES; Wilkinson J; El Rassi F; Schmidt S
  • Hemgolobin S-C Disease at the Emory University Georgia Comprehensive Sickle Cell Center at Grady Health System
    Volume: 128
    12/02/2016 Authors: Hunter A; Fasano RM; Eckman JR; McLemore ML; El Rassi F
  • Outcomes of Chronic Phase Chronic Myeloid Leukemia Patients Following Tyrosine Kinase Inhibitors Dose-Reductions
    Volume: 128
    12/02/2016 Authors: Kong JH; Khoury HJ; Winton EF; Heffner LT; Gaddh M; Arellano M; El-Rassi F; Kim AS; Jillella A; Bodo I
  • Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia?
    Clin Lymphoma Myeloma Leuk Volume: 16 Page(s): 466 - 471.e1
    08/01/2016 Authors: DeFilipp Z; Langston AA; Chen Z; Zhang C; Arellano ML; El Rassi F; Flowers CR; Kota VK; Al-Kadhimi Z; Veldman R
  • Sustained Complete Molecular Remission After Discontinuation of Tyrosine Kinase Inhibitors in Blast-Phase Chronic Myeloid Leukemia.
    J Clin Oncol Volume: 34 Page(s): e68 - e69
    03/10/2016 Authors: Hill BG; Shen AQ; El Rassi F; Khoury HJ
  • Clinical monitoring and management of complications related to chelation therapy in patients with -thalassemia.
    Expert Rev Hematol Volume: 9 Page(s): 151 - 168
    01/01/2016 Authors: Saliba AN; El Rassi F; Taher AT
  • Temperature and Humidity Effects on Acute Vaso-Occlusive Pain Episodes in Sickle Cell Disease
    Volume: 126
    12/03/2015 Authors: El Rassi F; Randall E; Stein SF; Khoury HJ; Eckman JR; McLemore ML
  • Outcomes of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia (CML) Who Switch to Imatinib Following Optimal Response to Second Generation Tyrosine Kinase Inhibitors
    Volume: 126
    12/03/2015 Authors: Kota VK; Winton EF; Arellano M; Jillella A; McLemore ML; El Rassi F; Khoury HJ
  • Daily Opioid Use Is Common in Adults with Sickle Cell Disease Presenting to an Acute Care Unit for Treatment of Vaso-Occlusive Pain
    Volume: 126
    12/03/2015 Authors: El Rassi F; Stoyanova N; Randall E; McLemore ML; Morris CR
  • Acute Chest Syndrome Rate at the Emory University Georgia Comprehensive Sickle Cell Center at Grady Health System
    Volume: 126
    12/03/2015 Authors: El Rassi F; Randall E; Stein SF; Khoury HJ; Eckman JR; McLemore ML
  • Predicting early blast transformation in chronic-phase chronic myeloid leukemia: is immunophenotyping the missing link?
    Cancer Volume: 121 Page(s): 872 - 875
    03/15/2015 Authors: El Rassi F; Bergsagel JD; Arellano M; Gaddh M; Jillella A; Kota V; Heffner LT; Winton EF; Khoury HJ
  • Early Blast Phase Transformation In Chronic Phase Chronic Myeloid Leukemia: Is Flow Cytometry The Missing Link?
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA Volume: 14 Page(s): S136 - S137
    09/01/2014 Authors: El Rassi F; Arellano M; Winton E; Heffner L; Gaddh M; Khoury HJ
  • Incidence and geographic distribution of adult acute leukemia in the state of Georgia.
    South Med J Volume: 107 Page(s): 497 - 500
    08/01/2014 Authors: El Rassi F; Ward KC; Flowers CR; Heffner LT; Waller EK; Winton EF; Vaughn J; Hill BG; Langston A; Nooka A
  • Sensitivity and specificity of cerebrospinal fluid flow cytometry for the diagnosis of leukemic meningitis in acute lymphoblastic leukemia/lymphoma.
    Leuk Lymphoma Volume: 55 Page(s): 1498 - 1500
    07/01/2014 Authors: Mitri Z; Siddiqui MT; El Rassi F; Holden JT; Heffner LT; Langston A; Waller EK; Winton E; McLemore M; Bernal-Mizrachi L
  • Venous access catheter-related thrombosis in patients with cancer.
    Leuk Lymphoma Volume: 55 Page(s): 501 - 508
    03/01/2014 Authors: Gaddh M; Antun A; Yamada K; Gupta P; Tran H; El Rassi F; Kim HS; Khoury HJ
  • Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies.
    Cancer Volume: 119 Page(s): 3784 - 3787
    11/01/2013 Authors: Antun AG; Gleason S; Arellano M; Langston AA; McLemore ML; Gaddh M; el Rassi F; Bernal-Mizrachi L; Galipeau J; Heffner LT
  • Advances in hematopoietic stem cell transplantation in chronic myeloid leukemia.
    Discov Med Volume: 16 Page(s): 179 - 186
    10/01/2013 Authors: Veldman R; El Rassi F; Holloway S; Langston A; Khoury HJ
  • Bosutinib: a SRC-ABL tyrosine kinase inhibitor for treatment of chronic myeloid leukemia.
    Pharmgenomics Pers Med Volume: 6 Page(s): 57 - 62
    08/05/2013 Authors: Rassi FE; Khoury HJ
  • Update on optimal management of acute myeloid leukemia.
    Clin Med Insights Oncol Volume: 7 Page(s): 181 - 197
    01/01/2013 Authors: El Rassi F; Arellano M
  • Incidence and Geographic Distribution of Adult Acute Lymphoblastic Leukemia in the State of Georgia
    Volume: 120
    11/16/2012 Authors: El Rassi F; Arellano M; Heffner LT; Waller EK; Winton EF; Ward K; Khoury HJ
  • Early diagnosis of acute myeloid leukemia by computed tomography scan.
    J Clin Oncol Volume: 30 Page(s): e207 - e208
    08/10/2012 Authors: El Rassi F; Little BP; Holloway S; Roberts D; Khoury HJ
  • Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassaemia intermedia.
    Br J Haematol Volume: 146 Page(s): 569 - 572
    09/01/2009 Authors: Taher A; Musallam KM; El Rassi F; Duca L; Inati A; Koussa S; Cappellini MD
  • Myocardial infarction in a 28-year-old thalassemia intermedia patient.
    Clin Appl Thromb Hemost Volume: 15 Page(s): 467 - 469
    01/01/2009 Authors: El Rassi FA; Ismaeel HA; Koussa SC; Taher AT
  • Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia.
    Haematologica Volume: 93 Page(s): 1584 - 1586
    10/01/2008 Authors: Taher A; El Rassi F; Isma'eel H; Koussa S; Inati A; Cappellini MD
  • Relation between iron-overload indices, cardiac echo-Doppler, and biochemical markers in thalassemia intermedia.
    Am J Cardiol Volume: 102 Page(s): 363 - 367
    08/01/2008 Authors: Isma'eel H; Chafic AHE; El Rassi F; Inati A; Koussa S; Daher R; Gharzuddin W; Alam S; Taher A
  • Complications of beta-thalassemia intermedia: a 12-year Lebanese experience.
    Am J Hematol Volume: 83 Page(s): 605 - 606
    07/01/2008 Authors: Taher A; El Rassi F; Ismaeel H; Inati A
  • CORRELATIONS OF NON TRANSFERRIN BOUND IRON LEVELS IN 74 PATIENTS WITH THALASSEMIA INTERMEDIA
    Volume: 93 Page(s): 342 - 342
    06/27/2008 Authors: El Rassi F; Taher A; Inati A; Koussa S; Cappellini MD
  • REFLECTIONS OF T2 MRI IN 19 THALASSEMIA INTERMEDIA PATIENTS
    Volume: 93 Page(s): 447 - 447
    06/27/2008 Authors: El Rassi F; Taher A; Inati A; Koussa S; Cappellini MD
  • REFLECTIONS OF T2 MRI IN 19 THALASSEMIA INTERMEDIA PATIENTS
    Volume: 93 Page(s): 447 - 447
    06/01/2008 Authors: El Rassi F; Taher A; Inati A; Koussa S; Cappellini MD
  • Thrombosis of the corpora cavernosa complicating lenalidomide therapy of myelofibrosis.
    Leuk Res Volume: 32 Page(s): 821 - 822
    05/01/2008 Authors: El Rassi FA; Tam CS; Carwile J; Verstovsek S
  • Beta-thalassemia intermedia: an overview.
    Pediatr Ann Volume: 37 Page(s): 322 - 328
    05/01/2008 Authors: El Rassi F; Cappellini MD; Inati A; Taher A
  • Hydatid cyst mimicking acute chest syndrome in a sickle thalassemia patient.
    Ann Hematol Volume: 87 Page(s): 331 - 332
    04/01/2008 Authors: Marrouche N; El Rassi F; Kanj N; Taher A
  • Overview of cardiac status in Thalassemia intermedia: The Lebanese experience
    Volume: 110 Page(s): 25B - 25B
    11/16/2007 Authors: Taher A; El Chafic A; Isma'eel H; El Rassi F; Inati A; Koussa S; Daher R; Alam S
  • Correlation of serum ferritin levels and liver iron concentration determined by R2*MRI in patients with thalassemia intermedia
    Volume: 110 Page(s): 22B - 22B
    11/16/2007 Authors: Taher A; El Rassi F; Ismaeel H; Koussa S; Inati A
  • High degree of iron burden in transfusion-naive thalassemia intermedia patients
    Volume: 92 Page(s): 301 - 301
    06/01/2007 Authors: Rassi F; Ismaeel H; Inati A; Koussa S; Habr D; Taher A
  • Complications of p-thalassemia intermedia: A 12-year Lebanese experience
    Volume: 92 Page(s): 430 - 431
    06/01/2007 Authors: Rassi F; Ismaeel H; Zeineh N; Charaffedine M; Inati A; Koussa S; Taher A
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements